“DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO”. Proceedings of the International Conference on Applied Science and Health, no. 2 (September 29, 2017): 81–85. Accessed November 7, 2024. https://publications.inschool.id/index.php/icash/article/view/880.